Результати пошуку - Shanthakumar Tyavanagimatt

  • Показ 1 - 9 результатів із 9
Уточнити результати
  1. 1
    Development of ST-246® for Treatment of Poxvirus Infections

    Development of ST-246® for Treatment of Poxvirus Infections за авторством Robert Jordan, Janet M. Leeds, Shanthakumar Tyavanagimatt, Dennis E. Hruby

    Опубліковано 2010
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

    Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor за авторством Robert Jordan, Deborah Tien, Tové C. Bolken, Kevin F. Jones, Shanthakumar Tyavanagimatt, Josef Strasser, Annie Frimm, Michael L. Corrado, Phoebe G. Strome, Dennis E. Hruby

    Опубліковано 2008
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    A potent Lassa virus antiviral targets an arenavirus virulence determinant

    A potent Lassa virus antiviral targets an arenavirus virulence determinant за авторством Ikenna G. Madu, Megan Files, Dima Gharaibeh, Amy L. Moore, Kie-Hoon Jung, Brian B. Gowen, Dongcheng Dai, Kevin F. Jones, Shanthakumar Tyavanagimatt, James R. Burgeson, Marcus J. Korth, Kristin Bedard, Shawn P. Iadonato, Sean M. Amberg

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

    A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein за авторством Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach, Aklile Berhanu, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Kristin A. Wineinger, Jessica Pagé, Chris Harver, Eric Stavale, Shanthakumar Tyavanagimatt, Melialani A. Stone, Ralf Bartenschlager, Pietro Scaturro, Dennis E. Hruby, Robert Jordan

    Опубліковано 2012
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

    Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers за авторством Jarasvech Chinsangaram, Kady M. Honeychurch, Shanthakumar Tyavanagimatt, Janet M. Leeds, Tové C. Bolken, Kevin F. Jones, Robert Jordan, Thomas Marbury, Jon Ruckle, Denis Mee-Lee, Eric A. Ross, Israel Lichtenstein, Margaret Pickens, Michael L. Corrado, Jean Μ. Clarke, Annie Frimm, Dennis E. Hruby

    Опубліковано 2012
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

    Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis за авторством Stephen T. Oh, Ruben A. Mesa, Claire Harrison, Prithviraj Bose, Aaron T. Gerds, Vikas Gupta, Bart L. Scott, Jean‐Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah Buckley, Shanthakumar Tyavanagimatt, Bryan Harder, Karisse Roman‐Torres, Jennifer A. Smith, Adam R. Craig, John Mascarenhas, Srđan Verstovšek

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

    ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification за авторством Robert Jordan, Arthur J. Goff, Annie Frimm, Michael L. Corrado, Lisa E. Hensley, Chelsea M. Byrd, Eric M. Mucker, Josh Shamblin, Tové C. Bolken, Carly Wlazlowski, Wendy Johnson, Jennifer Chapman, Nancy Twenhafel, Shanthakumar Tyavanagimatt, Adams Amantana, Jarasvech Chinsangaram, Dennis E. Hruby, John W. Huggins

    Опубліковано 2009
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

    Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase за авторством Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu, Dongcheng Dai, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Guang Yang, Shanthakumar Tyavanagimatt, Chris Harver, Kristin A. Wineinger, Jessica Pagé, Eric Stavale, Melialani A. Stone, Kathleen Fuller, Candace Lovejoy, Janet M. Leeds, Dennis E. Hruby, Robert Jordan

    Опубліковано 2013
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis

    Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis за авторством Aaron T. Gerds, Michael R. Savona, Bart L. Scott, Moshe Talpaz, Miklós Egyed, Claire Harrison, Abdulraheem Yacoub, Alessandro M. Vannucchi, Adam J. Mead, Jean‐Jacques Kiladjian, Jennifer O’Sullivan, Valentín García‐Gutiérrez, Prithviraj Bose, Raajit K. Rampal, Carole B. Miller, Jeanne Palmer, Stephen T. Oh, Sarah Buckley, Diane R. Mould, Kaori Ito, Shanthakumar Tyavanagimatt, Jennifer A. Smith, Karisse Roman‐Torres, Sri Devineni, Adam R. Craig, John Mascarenhas

    Опубліковано 2020
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: